{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:44:30Z","timestamp":1792086270811,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-tuberculous mycobacteria (NTM) are a group of bacteria that cause rare lung infections and are increasingly recognized as causative agents of opportunistic and device-associated infections in humans. In Gabon, there is a lack of data on NTM species identification and drug susceptibility. The aim of this study was to identify the frequency of NTM species and their genotypic susceptibility pattern to commonly used antibiotics for NTM infections in Gabon.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was conducted at the CERMEL TB laboratory from January 2020 to December 2022, NTM subspecies identification and drug susceptibility testing to macrolides and aminoglycosides were performed using the genotype NTM-DR kit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study found that out of 524 culture-positive specimens, 146 (28%) were NTM, with the predominant group being <jats:italic>Mycobacterium avium<\/jats:italic> complex (MAC) and <jats:italic>Mycobacterium abscessus<\/jats:italic> complex (MABC). All MAC isolates were fully susceptible to macrolides and aminoglycosides, while five MABC isolates carried mutations indicative of reduced susceptibility to macrolide and aminoglycoside drugs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings suggest that clinicians may use macrolides and aminoglycosides to manage NTM infections caused by MAC, but further investigation is required to determine MABC drug susceptibility.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08617-x","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:03:23Z","timestamp":1696334603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambar\u00e9n\u00e9, Gabon\u2014a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Micheska Epola Dibamba","family":"Ndanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabar Babatund\u00e9 Pacome Achimi Agbo","family":"Abdul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Ronald","family":"Edoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy Arnault Rogue Mfoumbi","family":"Ibinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayod\u00e9 Romeo","family":"Adegbite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhett Chester","family":"Mevyann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Mebiame","family":"Biyogho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Mahoumbou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stredice","family":"Manguinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina Mbenga","family":"Roguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Lell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Gottfried","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham Sunday","family":"Alabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Peter","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayola Akim","family":"Adegnika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"8617_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccm.2014.10.003","volume":"36","author":"JO Falkinham","year":"2015","unstructured":"Falkinham JO. Environmental sources of nontuberculous mycobacteria. Clin Chest Med. 2015;36:35\u201341.","journal-title":"Clin Chest Med"},{"key":"8617_CR2","first-page":"1007","volume":"60","author":"KA Harris","year":"2015","unstructured":"Harris KA, Underwood A, Kenna DTD, Brooks A, Kavaliunaite E, Kapatai G, Tewolde R, Aurora P, Dixon G. Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of mycobacterium abscessus in a cohort of pediatric cystic fibrosis patients. Clin Infect Dis. 2015;60:1007\u201316.","journal-title":"Clin Infect Dis"},{"key":"8617_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2014.10.001","volume":"36","author":"JR Honda","year":"2015","unstructured":"Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med. 2015;36:1\u201311.","journal-title":"Clin Chest Med"},{"key":"8617_CR4","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/S0950268820003088","volume":"149","author":"H Zhang","year":"2020","unstructured":"Zhang H, Luo M, Zhang K, Yang X, Hu K, Fu Z, Zhang L, Wu P, Wan D, Han M, Wang X. Species identification and antimicrobial susceptibility testing of non-tuberculous mycobacteria isolated in Chongqing, Southwest China. Epidemiol Infect. 2020;149:e7.","journal-title":"Southwest China. Epidemiol Infect."},{"key":"8617_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, Von Reyn CF, Wallace RJ, Winthrop K. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"key":"8617_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1471-2180-13-89","volume":"13","author":"RM Thomson","year":"2013","unstructured":"Thomson RM, Carter R, Tolson C, Coulter C, Huygens F, Hargreaves M. Factors associated with the isolation of Nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia. BMC Microbiol. 2013;13:89.","journal-title":"BMC Microbiol."},{"key":"8617_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-05925-y","volume":"21","author":"MJ Donohue","year":"2021","unstructured":"Donohue MJ. Epidemiological risk factors and the geographical distribution of eight Mycobacterium species. BMC Infect Dis. 2021;21:1\u201311.","journal-title":"BMC Infect Dis"},{"key":"8617_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.PULMOE.2022.01.011","author":"A Santos","year":"2022","unstructured":"Santos A, Carneiro S, Silva A, Gomes JP, Macedo R. Nontuberculous Mycobacteria in Portugal: trends from the last decade. Pulmonology. 2022. https:\/\/doi.org\/10.1016\/J.PULMOE.2022.01.011.","journal-title":"Pulmonology"},{"key":"8617_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ccm.2014.10.004","volume":"36","author":"SH Kasperbauer","year":"2015","unstructured":"Kasperbauer SH, De Groote MA. The treatment of rapidly growing mycobacterial infections. Clin Chest Med. 2015;36:67\u201378.","journal-title":"Clin Chest Med"},{"key":"8617_CR10","doi-asserted-by":"crossref","unstructured":"Wang D, Lin W, Cheng H, Bao X, Xu D, Liang S, Jiang Y, Wang C. Clinical Characteristics and Antimicrobial Susceptibility of Mycobacterium intracellulare and Mycobacterium abscessus Pulmonary Diseases: a retrospective study. Can J Infect Dis Med Microbiol = J Can des Mal Infect la Microbiol M\u00e9dicale. 2022;2022:2642200.","DOI":"10.1155\/2022\/2642200"},{"key":"8617_CR11","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/jac\/dkx021","volume":"72","author":"F Mougari","year":"2017","unstructured":"Mougari F, Loiseau J, Veziris N, Bernard C, Bercot B, Sougakoff W, Jarlier V, Raskine L, Cambau E, Aubry A, Brossier F, Chauffour A, Lecorche E, Reibel F, Robert J. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria. J Antimicrob Chemother. 2017;72:1669\u201377.","journal-title":"J Antimicrob Chemother"},{"key":"8617_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-12175-z","volume":"7","author":"C Okoi","year":"2017","unstructured":"Okoi C, Anderson STB, Antonio M, Mulwa SN, Gehre F, Adetifa IMO. Non-tuberculous Mycobacteria isolated from pulmonary samples in sub-Saharan Africa - a systematic review and meta analyses. Sci Rep. 2017;7:1\u201312.","journal-title":"Sci Rep"},{"key":"8617_CR13","doi-asserted-by":"crossref","unstructured":"Epola Dibamba Ndanga M, Achimi Agbo Abdul JBP, Edoa JR, Chester Mevyann R, Adegbite BR, Mfoumbi A, Mebiame Biyogho C, Beh Mba R, Mahoumbou J, McCall MBB, Grobusch MP, Adegnika AA, Alabi AS. Non-tuberculous mycobacteria isolation from presumptive tuberculosis patients in Lambar\u00e9n\u00e9, Gabon. Trop Med Int Heal. 2022;27:438\u201344.","DOI":"10.1111\/tmi.13736"},{"key":"8617_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijid.2016.11.404","volume":"56","author":"AS Alabi","year":"2017","unstructured":"Alabi AS, Traor\u00e9 AN, Loembe MM, Ateba-Ngoa U, Frank M, Adegnika AA, Lell B, Mahoumbou J, K\u00f6hler C, Kremsner PG, Grobusch MP. Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings. Int J Infect Dis. 2017;56:81\u20134.","journal-title":"Int J Infect Dis"},{"key":"8617_CR15","doi-asserted-by":"publisher","first-page":"106776","DOI":"10.1016\/j.actatropica.2022.106776","volume":"238","author":"AM Mekota","year":"2023","unstructured":"Mekota AM, Gillespie SH, Hoelscher M, Diacon AH, Dawson R, Churchyard G, Sanne I, Minja L, Kibiki G, Maboko L, Lakhi S, Joloba M, Alabi A, Kirenga B, McHugh TD, Grobusch MP, Boeree MJ. Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: the PanACEA approach. Acta Trop. 2023;238:106776.","journal-title":"Acta Trop."},{"key":"8617_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00508-020-01794-8","volume":"133","author":"M Ramharter","year":"2021","unstructured":"Ramharter M, Agnandji ST, Adegnika AA, Lell B, Mombo-Ngoma G, Grobusch MP, McCall M, Muranaka R, Kreidenweiss A, Velavan TP, Esen M, Schaumburg F, Alabi A, Druml C, Mordm\u00fcller B, K\u00f6hler C, Kremsner PG. Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9 (CERMEL) Gabon. Wien Klin Wochenschr. 2021;133:500\u20138.","journal-title":"Wien Klin Wochenschr"},{"key":"8617_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"8617_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95: 103208.","journal-title":"J Biomed Inform"},{"key":"8617_CR19","volume-title":"GenoType Mycobacterium CM instructions for use.","author":"Hain LifeScience","year":"2014","unstructured":"Hain LifeScience. GenoType Mycobacterium CM instructions for use. 2014."},{"key":"8617_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijid.2016.03.006","volume":"45","author":"JE Stout","year":"2016","unstructured":"Stout JE, Koh WJ, Yew WW. Update on pulmonary disease due to non-tuberculous mycobacteria. Int J Infect Dis. 2016;45:123\u201334.","journal-title":"Int J Infect Dis"},{"key":"8617_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/thx.2008.110957","volume":"64","author":"J Van Ingen","year":"2009","unstructured":"Van Ingen J, Bendien SA, De Lange WCM, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, Van Soolingen D. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region The Netherlands. Thorax. 2009;64:502\u20136.","journal-title":"Thorax"},{"key":"8617_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265358","volume":"17","author":"TG Maya","year":"2022","unstructured":"Maya TG, Komba EV, Mensah GI, Mbelele PM, Mpagama SG, Mfinanga SG, Addo KK, Kazwala RR. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania. PLoS ONE. 2022;17: e0265358.","journal-title":"PLoS ONE"},{"key":"8617_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12890-019-0901-z","volume":"19","author":"SC Park","year":"2019","unstructured":"Park SC, Kang MJ, Han CH, Lee SM, Kim CJ, Lee MJ, Kang YA. Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study. BMC Pulmon Med. 2019;19:140.","journal-title":"BMC Pulmon Med."},{"key":"8617_CR24","first-page":"156","volume":"183","author":"PJ Dodd","year":"2016","unstructured":"Dodd PJ, Looker C, Plumb ID, Bond V, Schaap A, Shanaube K, Muyoyeta M, Vynnycky E, Godfrey-Faussett P, Corbett EL, Beyers N, Ayles H, White RG. Age- and sex-specific social contact patterns and incidence of Mycobacterium tuberculosis infection. Am J Epidemiol. 2016;183:156\u201366.","journal-title":"Am J Epidemiol"},{"key":"8617_CR25","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1164\/rccm.200805-686OC","volume":"178","author":"RD Kim","year":"2008","unstructured":"Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, Lin JP, Jolley C, Sorbara L, Raffeld M, Hill S, Avila N, Sachdev V, Barnhart LA, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med. 2008;178:1066.","journal-title":"Am J Respir Crit Care Med"},{"key":"8617_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12939-018-0900-3","volume":"17","author":"DB De Castro","year":"2018","unstructured":"De Castro DB, De Seixas Maciel EMG, Sadahiro M, Pinto RC, De Albuquerque BC, Braga JU. Tuberculosis incidence inequalities and its social determinants in Manaus from 2007 to 2016. Int J Equity Health. 2018;17:187.","journal-title":"Int J Equity Health."},{"key":"8617_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/ijmr.IJMR_902_20","volume":"152","author":"S Sharma","year":"2020","unstructured":"Sharma S, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020;152:185\u2013226.","journal-title":"Indian J Med Res"},{"key":"8617_CR28","doi-asserted-by":"publisher","first-page":"e00516","DOI":"10.1128\/JCM.00516-19","volume":"57","author":"HJ Huh","year":"2019","unstructured":"Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Yong Lee N. GenoType NTM-DR performance evaluation for identification of mycobacterium avium complex and mycobacterium abscessus and determination of clarithromycin and amikacin resistance. J Clin Microbiol. 2019;57:e00516\u201319.","journal-title":"J Clin Microbiol."},{"key":"8617_CR29","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1128\/AAC.01275-08","volume":"53","author":"KA Nash","year":"2009","unstructured":"Nash KA, Brown-Elliott AB, Wallace RJ. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53:1367\u201376.","journal-title":"Antimicrob Agents Chemother"},{"key":"8617_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.diagmicrobio.2014.10.007","volume":"81","author":"SY Kim","year":"2015","unstructured":"Kim SY, Kim CK, Bae IK, Jeong SH, Yim JJ, Jung JY, Park MS, Kim YS, Kim SK, Chang J, Kang YA. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea. Diagn Microbiol Infect Dis. 2015;81:107\u201311.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"8617_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140166","volume":"10","author":"M Rubio","year":"2015","unstructured":"Rubio M, March F, Garrig\u00f3 M, Moreno C, Espa\u00f1ol M, Coll P. Inducible and acquired clarithromycin resistance in the mycobacterium abscessus complex. PLoS ONE. 2015;10: e0140166.","journal-title":"PLoS ONE"},{"key":"8617_CR32","doi-asserted-by":"crossref","unstructured":"Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, Ormerod P, Shingadia D, Smith D, Whitehead N, Wilson R, Floto RA. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). 2017.","DOI":"10.1136\/bmjresp-2017-000242"},{"key":"8617_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2853-3","volume":"17","author":"KK Addo","year":"2017","unstructured":"Addo KK, Addo SO, Mensah GI, Mosi L, Bonsu FA. Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana. BMC Infect Dis. 2017;17:1\u20137.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08617-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08617-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08617-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T08:04:17Z","timestamp":1700381057000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08617-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8617"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08617-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"21 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of the Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9 (CERMEL) under the number CEI-014-2019. Written informed consent was obtained from all volunteers prior to study, study identification numbers and laboratory serial numbers were used instead of patient numbers. names so that the identity of each participant remains completely anonymous.All work on human tissue samples, and human data reporting in the manuscript were performed in accordance with relevant guidelines and regulations such as the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"651"}}